https://www.selleckchem.com/pr....oducts/jr-ab2-011.ht
In adhesion assays using recombinant host receptors, sickle-trait reduced adhesion by 73-86% to CD36 and 83% to EPCR. Similarly, sickle-trait reduced the surface expression of EPCR-binding PfEMP1. In conclusion, Sickle-cell trait does not directly affect var gene transcription but does reduce the surface expression and function of PfEMP1. This provides a direct mechanism for protection against severe malaria conferred by sickle-trait hemoglobin. Trial Registration ClinicalTrials.gov Identifier NCT02645604.Three months of weekly rifap
Aimer
Commentaire
Partagez
